An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Twist Bioscience to Present at Upcoming Virtual Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
SOUTH SAN FRANCISCO, Calif. – Twist Bioscience Corporation (NASDAQ: TWST) announced that CEO Emily M. Leproust will present at two upcoming virtual investor conferences. The first is the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 29 at 10:00 a.m. ET, followed by the Evercore ISI HealthCONx Conference on November 30 at 10:30 a.m. ET. Investors can access the fireside chats via the company’s Investor Calendar page. Twist is a leader in synthetic biology, specializing in high-quality synthetic DNA for various industries.
Positive
None.
Negative
None.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the following upcoming virtual investor conferences:
Piper Sandler 33rd Annual Virtual Healthcare Conference on Monday, November 29; fireside chat at 10:00 a.m. Eastern Time.
4th Annual Evercore ISI HealthCONx Conference on Tuesday, November 30; fireside chat at 10:30 a.m. Eastern Time.
The fireside chats can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chats will be archived for a period of 30 days following the conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
